Skip to main content

BIOTECHS DEMAND DISCIPLINE, CLARITY, AND DEPTH

Rare Disease Expertise Built on Precision, Adaptability, and Global Insight

Rare disease development requires a different level of discipline—where small patient populations, complex protocols, and limited clinical precedent create unique operational and scientific challenges. HiRO’s rare disease teams bring together global experience, advanced biometrics, and regionally informed execution to guide programs with clarity and confidence.

Through our Linkage™ Approach, we connect people, data, and systems into a unified framework—helping sponsors reduce uncertainty, navigate complexity, and make decisions grounded in real-world insight. From ultra-rare conditions to more established orphan indications, our work reflects the structure, adaptability, and precision rare disease programs demand.

Our experience spans global programs where recruitment, endpoint definition, and regulatory alignment must be handled with exceptional care. This isn’t just rare disease experience—it’s the ability to bring order to environments where variability is the norm and every patient matters.

Rare Disease Indicators

Rare disease programs require specialized expertise across a wide range of therapeutic areas, often with highly specific patient populations and limited clinical pathways. HiRO supports programs across:

Genetic and Inherited Disorders

  • Rare metabolic diseases
  • Mitochondrial disorders
  • Lysosomal storage diseases

Hematologic and Immunologic Disorders

  • Rare blood disorders
  • Autoimmune and inflammatory rare conditions

Ultra-Rare and Orphan Indications

  • Low-prevalence conditions requiring global site coordination
  • Programs requiring specialized recruitment strategies and patient identification

Neurological and Neuromuscular Disorders

  • Rare epilepsy syndromes
  • Neuromuscular conditions
  • Pediatric neurological diseases

Rare Disease Experience By The Numbers

Our rare disease experience reflects the complexity, global coordination, and patient-centered execution required to deliver meaningful outcomes in small populations.

200

Team Members With Direct Experience

224

Global CNS Studies

5K

Trials

5K

Patients

How HiRO Advanced a Phase II
Rare Disease Program

See how HiRO supported a Phase II Primary Biliary Cholangitis (PBC) study through disciplined endpoint strategy, adaptive enrollment planning, and steady operational execution. This case study highlights HiRO’s ability to strengthen recruitment momentum, support FDA-aligned study design, and deliver critical analyses within required timelines for a complex rare disease program.

Rare Diseases: Phase II Primary Biliary Cholangitis

Download Study
110

Adult patients successfully enrolled in the Phase II PBC study.

220

Rare disease clinical trials supported by HiRO globally.

DISCIPLINE MEETS ADAPTIVE EXECUTION

A Modern Approach To
Rare Disease Clinical Trials

Rare disease trials demand a partner who can bring structure to complexity and adaptability to every decision. With limited patient populations, evolving endpoints, and regulatory nuance, sponsors need guidance that is both disciplined and flexible. HiRO combines biometrics rigor, transparent communication, and thoughtful oversight to help teams move forward with confidence.

By integrating global operational strength with deep rare disease expertise, we ensure every program benefits from unified standards and connected teams. Through our Linkage™ Approach, studies advance with consistent communication, aligned expectations, and the collective insight of shared experience across regions.

Regulatory Confidence
From Strategy To Submission

We don’t just manage timelines—we help rare disease sponsors navigate the full regulatory pathway with confidence. From early strategy and orphan designation through submission and beyond, our teams bring deep expertise in rare disease development and global regulatory expectations.

Proactive Planning
Anticipating recruitment challenges, endpoint variability, and regulatory considerations before they impact timelines.

Integrated Approach
Aligning clinical, biometrics, and operational strategies to support efficient execution and high-quality data.

Global Perspective
Supporting multi-regional programs where patient populations are dispersed and coordination is critical.

Collaborative Partnership
Working closely with sponsors to ensure clarity, compliance, and confident decision-making at every stage.

Our goal is simple: help you move from concept to clinic with the precision, adaptability, and confidence rare disease development demands.

Book A Meeting Today With
Our Oncology Team

Schedule Today